Featured Products
Our Promise to You
Guaranteed product quality, expert customer support
ONLINE INQUIRY
HeLa 422
Cat.No.: CSC-6262W
Species: Homo sapiens, human
Source: cervix
Morphology: continuous culture, grown as monolayer, morphology epithelial-like
Culture Properties: Monolayer
- Specification
- Q & A
- Customer Review
CTCs may harbor genetic mutations associated with resistance to treatment, serving as a reservoir for the development of resistant cancer cell populations.
Ask a Question
Average Rating: 4.0 | 1 Scientist has reviewed this product
A crucial tool
We were impressed by the seamless integration of these products into our cellular applications, enabling streamlined and efficient workflows for cell culture maintenance and experimentation.
17 May 2023
Ease of use
After sales services
Value for money
Write your own review
- You May Also Need
Description: The HeLa 382 cell line is a subclone of the cell line HeLa. The original HeLa cell line was derived from a cervical carcinoma from a 31 year old female and the HeLa 382 cell line was transfected with pBact, expression vector under control of the human beta actin promotor, resistant to G418S. Control to HeLa 422 and HeLa 432.
Description: Transfected with the exon 4 defective variant of ER-pBact cDNA, human estrogen receptor cDNA, under control of the human beta actin promotor, resistant to G418S.
Species: human, Black female 31 years old
Tissue: cervix
Tumor: carcinoma, epitheloid
Original line: HeLa
Description: These cells were cloned from the GIRARDI HEART cell line (passage #623) in 1981 and were thought to "represent human heart cells"; however, isoenzyme analysis (Nelson-Rees et al., Science 191: 96-97, 1976) and DNA fingerprinting at the Creative Bioarray established unequivocally that this cell line must be considered de facto a subclone of HELA; cells were described to be sensitive to various toxins and hormones
Description: These cells were cloned from the GIRARDI HEART cell line (passage #623) in 1981 and were thought to "represent human heart cells"; however, isoenzyme analysis (Nelson-Rees et al., Science 191: 96-97, 1976) and DNA fingerprinting at the Creative Bioarray established unequivocally that this cell line must be considered de facto a subclone of HELA; cells were described to be sensitive to various toxins and hormones
Description: Established from the ascitic fluid of a 69-year-old Caucasian woman with endometrial carcinoma in relapse in 1985
